Simvastatin reduces atherogenesis and promotes the expression of hepatic genes associated with reverse cholesterol transport in apoE-knockout mice fed high-fat diet
<p>Abstract</p> <p>Background</p> <p>Statins are first-line pharmacotherapeutic agents for hypercholesterolemia treatment in humans. However the effects of statins on atherosclerosis in mouse models are very paradoxical. In this work, we wanted to evaluate the effects o...
Main Authors: | Tian Hua, Yu Yang, Zhao Zhenmei, Liu Jia, Song Guohua, Yao Shutong, Li Guoli, Qin Shucun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-01-01
|
Series: | Lipids in Health and Disease |
Online Access: | http://www.lipidworld.com/content/10/1/8 |
Similar Items
-
ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis
by: Godfrey S. Getz, et al.
Published: (2016-05-01) -
Inhibitory effect of the combination therapy of simvastatin and pinocembrin on atherosclerosis in apoE-deficient mice
by: Sang Hui, et al.
Published: (2012-12-01) -
Effects of Six Weeks of Hypoxia Exposure on Hepatic Fatty Acid Metabolism in ApoE Knockout Mice Fed a High-Fat Diet
by: Yangwenjie Wang, et al.
Published: (2022-10-01) -
Canagliflozin Attenuates Hepatic Steatosis and Atherosclerosis Progression in Western Diet-Fed ApoE-Knockout Mice
by: Zuo Q, et al.
Published: (2022-12-01) -
LXR Agonist T0901317′s Hepatic Impact Overrules Its Atheroprotective Action in Macrophages, Driving Early Atherogenesis in Chow-Diet-Fed Male Apolipoprotein E Knockout Mice
by: Menno Hoekstra, et al.
Published: (2024-04-01)